Table 3 Odds ratios (ORs)^a of metabolic syndrome (MetS) by sleep duration, the Health Examinees-Gem (HEXA-G) study 2004–2013

Men^c

4906

29,141

10,213

670

MetS^b

1.12 (1.05–1.19)

Ref

1.01 (0.96–1.06)

1.28 (1.08–1.50)

 WC ≥90 cm

1.15 (1.08–1.23)

Ref

0.98 (0.93–1.03)

1.15 (0.97–1.35)

 Serum TG ≥150 mg/dL

1.03 (0.97–1.10)

Ref

1.09 (1.04–1.15)

1.33 (1.14–1.56)

 Serum HDL-C ≤ 40 mg/dL

0.98 (0.91–1.05)

Ref

1.04 (0.98–1.10)

1.12 (0.94–1.34)

 BP ≥130/85 mmHg

1.05 (0.98–1.11)

Ref

0.95 (0.91–1.00)

0.96 (0.82–1.12)

 Fasting glucose ≥100 mg/dL

1.02 (0.96–1.09)

Ref

1.00 (0.95–1.05)

1.07 (0.91–1.26)

Women^c

11,277

53,764

22,124

1513

MetS^b

1.05 (1.00–1.10)

Ref

1.08 (1.04–1.12)

1.40 (1.24–1.58)

 WC ≥80 cm

1.09 (1.04–1.14)

Ref

0.99 (0.96–1.02)

1.14 (1.02–1.27)

 Serum TG ≥150 mg/dL

1.01 (0.97–1.07)

Ref

1.10 (1.05–1.14)

1.41 (1.25–1.58)

 Serum HDL-C ≤ 50 mg/dL

0.96 (0.92–1.00)

Ref

1.08 (1.04–1.11)

1.24 (1.12–1.38)

 BP ≥130/85 mmHg

1.03 (0.99–1.08)

Ref

1.01 (0.98–1.05)

1.11 (0.99–1.24)

 Fasting glucose ≥100 mg/dL

1.07 (1.02–1.13)

Ref

1.07 (1.02–1.11)

1.39 (1.23–1.57)